Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Biopolymers|January 1, 1990
Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifenC A O'Brian, C G Ioannides, N E Ward, et al.Biochemical and Biophysical Research Communications|December 14, 1984
Sulfoxide configuration in sparsomycin determines time-dependent and competitive inhibition of peptidyl transferaseR J Ash, G A Flynn, R M Liskamp, et al.Journal of Virology|June 1, 1983
Structure of glycosylated and unglycosylated gag and gag-pol precursor proteins of Moloney murine leukemia virusC J Saris, J van Eenbergen, R M Liskamp, et al.Journal of the National Cancer Institute|June 1, 1986
Triphenylethylenes: a new class of protein kinase C inhibitorsC A O'Brian, R M Liskamp, D H Solomon, et al.Journal of Medicinal Chemistry|March 1, 1984
Structure-activity relationships of sparsomycin and its analogues. Octylsparsomycin: the first analogue more active than sparsomycinR M Liskamp, J H Colstee, H C Ottenheijm, et al.Journal of Computer-Aided Molecular Design|February 1, 1992
Computer-aided molecular modeling and design of DNA-inserting moleculesF J van der Klein-de Gunst, J H van Boom, R M LiskampBioorganic & Medicinal Chemistry|July 31, 1999
Increased stability of peptidesulfonamide peptidomimetics towards protease catalyzed degradationD B de Bont, K M Sliedregt-Bol, L J Hofmeyer, et al.The Journal of Biological Chemistry|January 25, 1993
A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitorT Eichholtz, D B de Bont, J de Widt, et al.Cellular Immunology|November 1, 1990
Inhibition of IL-2 receptor induction and IL-2 production in the human leukemic cell line Jurkat by a novel peptide inhibitor of protein kinase CC G Ioannides, R S Freedman, R M Liskamp, et al.Cytokine|February 1, 1997
TNF-mediated cytotoxicity of L929 cells: role of staurosporine in enhancement of cytotoxicity and translocation of protein kinase C isozymesM A O'Connell, D Kelleher, R M Liskamp, et al.Pageof 4